# PROALLOSTERA PHARMACEUTICALS, INC.: Targeting Proteasome Dysfunction for the Treatment of Alzheimer’s Disease

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | PROALLOSTERA PHARMACEUTICALS, INC. |
| Location | HONDO, TX |
| Project | Targeting Proteasome Dysfunction for the Treatment of Alzheimer’s Disease |
| Project number | 1R41AG099556-01A1 |
| Mechanism | R41 |
| Institute | National Institute on Aging |
| Award | $249,999 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-23 to 2028-05-31 |
| UEI | QMQVRDCLJ1Y9 |

## Why this score
- Award of $249,999.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11419115). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.